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Hh signaling controls cell proliferation and differenti-
ation in processes that range from insect segmenta-
tion and limb formation to vertebrate neural tube de-
velopment and bone differentiation. Moreover, Hh
signaling appears to regulate stem cell homeostasis
in adult tissues, while persistent Hh pathway activity
has pathological consequences in a number of can-
cers. Two recent meetings, a Karolinska Institute No-
bel conference (August 22-24, 2004) and a joint EMBO
and Juan March Institute workshop (October 25-27,
2004), provided the opportunity to take stock of the
progress that has been made in understanding Hh
signaling and also to remind us of the many ques-
tions that still remain unanswered.
Introduction
The hedgehog (hh) family of genes owe their discovery
and name to the genetic screens carried out in Dro-
sophila embryos by Nusslein-Volhard and Wieschaus.
Among the mutants they described, a group was iden-
tified that had acquired, in place of the normal discon-
tinuous arrangement of denticles, an uninterrupted
lawn of these hair-like bristles sprouting through the
embryonic cuticle. The similarity in appearance to the
spines of a hedgehog immediately suggested a name.
It was another decade before the gene encoding
hedgehog was identified, revealing it to be the founding
member of a new class of secreted intercellular signal-
ing proteins. Shortly after, vertebrate orthologs were
cloned, and it became clear that these Hedgehog pro-
teins regulate the growth, patterning, and morphogene-
sis of many different tissues (Ingham and McMahon,
2001). In the years since, much progress has been
made in understanding the biological role of these pro-
teins and the mechanism of their signaling pathway.
Here we have attempted to summarize some of the
highlights of two recent meetings on this topic, al-
though we must apologize to many excellent speakers
that we are not able to mention due to space con-
straints.*Correspondence: james.briscoe@nimr.mrc.ac.uk (J.B.); pascal.
therond@unice.fr (P.T.)The Unusual Secretion and Spread of Hh
The identification of Hh as a secreted intercellular sig-
naling molecule has focused attention on the mecha-
nism by which Hh ligand spreads through responding
tissue. The atypical biosynthesis of the active Hh sig-
naling peptide has added to the importance and conten-
tiousness of this question. Immature Hh protein enters
the secretory pathway where proteolytic autoprocess-
ing and lipididation produces an N-terminal Hh peptide
modified on the N and C termini by palmitoyl and
cholesteryl moieties, respectively (Mann and Beachy,
2004). Despite these lipid modifications, normally ex-
pected to tether a protein to the membrane restricting
its spread, the evidence indicates that Hh proteins act
over a long range in developing tissues. Moreover,
genetic screens have identified various molecules nec-
essary for this long-range action of Hh proteins; these
include the transmembrane transporter-like protein Dis-
patched (Disp), the heparan sulfate proteoglycans
Dally-like (Dlp) and Dally, and enzymes such as Sulfate-
less and Tout velu (Ttv) that are required for heparan
sulfate biosynthesis.
Clearly an important issue is unravelling the mecha-
nisms involved in transporting Hh from its source to
distant target cells. T. Kornberg (UCSF, San Francisco)
proposed that actin-based membrane extensions, or
“cytonemes,” produced by cells at distance from Hh
source, might be responsible for a direct transfer of Hh
to target cells (Ramirez-Weber and Kornberg, 1999).
S. Eaton (MPI, Dresden) presented another view of Hh
transport with recent advances on the characterization
of “argosomes” — structures proposed to transport
signals such as Hh and Wg (Greco et al., 2001). Extrac-
tion and purification of argosomes yielded lipidic par-
ticles containing Wg, Hh, and GPi-linked proteins along
with ApoLII, a peptide derived from the precursor mole-
cule, Lipophorin, which is produced by the fat body (an
organ with endocrine and storage function). Unfortu-
nately, no mutants are available in Lipophorin, but RNA
interference (RNAi)-mediated disruption of its expres-
sion triggered an accumulation of lipid droplets in the
fat body. Concomitantly, in the wing disc, a location re-
mote from the fat body, reduction in the expression of
a long-range target of Hh was observed, whereas ex-
pression of a shorter range target was normal. Controls
suggested that this was a specific defect in Hh signal-
ing and not a secondary consequence of changes in
lipid metabolism. Thus, Lipophorin appears to be a
component of argosomes and might facilitate the long-
range movement of lipid-linked morphogens such as
Wg and Hh.
I. Guerrero (University of Madrid) described another
Drosophila protein, Shifted, that appears to influence
the range of Hh action in the wing imaginal disc. Shifted
interacts with Hh protein and can be seen colocalizing
with Hh in vivo; mutation of shifted results in a reduced
range of Hh signaling as well as a lower level of Hh at
the plasma membrane of producing cells. The activity
of Shifted appears restricted to the cholesterol-modi-
fied form of Hh, as loss of shifted does not affect the
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cpalmitoyl adduct. Clonal analysis indicated that Shifted
acts non-cell autonomously, and, consistent with this, D
lshifted encodes a secreted molecule, the Drosophila
ortholog of vertebrate Wif-1 (Wnt interacting factor 1). d
1Previous studies indicated that vertebrate WIF-1 binds
to Wnt proteins and blocks Wnt activity in Xenopus m
o(Hsieh et al., 1999). Surprisingly, Shifted appears to
have no effect on Wg range or activity, suggesting that i
qShifted is specific to Hh regulation despite the observa-
tion that human WIF-1 inhibited Wg signaling when ex- c
pressed in Drosophila. A paper describing this work ap-
pears in this issue of Developmental Cell (Gorfinkiel et f
bal. (2005), and see also Glise et al. (2005) in this issue).
More investigation is certainly required to better under- s
tstand the functions of Shifted and in order to determine
if its principal role concerns either Hh stability or Hh t
Pmovement or if stabilization of Hh in the extracellular
matrix is required for Hh movement. g
sA central and much discussed issue at both confer-
ences was whether the lipid modifications of Hh are D
snecessary for long-range activity. P. Thérond (ISDBC,
Nice) and P-T. Chuang (UCSF, San Francisco) ad- I
mdressed this point. Comparison of different forms of Hh
in Drosophila indicated that cholesterol, but not palmi- E
ctoyl, modification of Hh is necessary for the generation
of accretions or “large punctate structures” containing t
wHh protein on the apical surface of epithelial cells (Gal-
let et al., 2003). This appeared to depend on the activity t
wof the Sterol Sensing Domain-containing Disp, as in the
absence of Disp or cholesterol modification of Hh, Hh h
aaccumulated on the basal lateral surface of cells and
was unable to signal at long range. Thérond presented s
oevidence that the movement of the Hh accretions de-
pended on the activity of proteoglycans synthesized by
vthe heparan sulfate polymerase Ttv. These data sug-
gest that the cholesterol moiety is required for long- f
Brange Hh movement and indicate that this is evolution-
arily conserved, as mice expressing a noncholesterol i
aform of the vertebrate Hh, Sonic hedgehog, also appear
to have a more restricted range of action in the limb l
t(Lewis et al., 2001). Chuang presented data from
knockout mice deficient in skinny hedgehog, a gene c
ithat catalyzes Hh palmitoylation, demonstrating that
palmitoylation of Shh is also required for long-range o
zsignaling in the limb (Chen et al., 2004). Both Thérond
and Chuang provided evidence that Hh lipid modifica- t
Vtions are required for producing a soluble multimeric
protein complex (Zeng et al., 2001) and proposed that n
lthis complex is involved in long-range activity. Whether
this complex is related to argosomes needs further in- s
ivestigation.
The production of an active long-range Hh signal in b
svertebrates also requires Disp (Caspary et al., 2002; Ma
et al., 2002). A. McMahon (Harvard University, Cam- t
hbridge) described a hypomorphic allele of mouse Disp1
(mDisp12). In contrast to a null allele of Disp1 in which o
there is a complete absence of a long-range Shh re-
sponse, in the neural tube of mouse embryos homozy- h
Dgous for mDisp12, only the cell types characteristic of
the highest responses to Shh were lost (Tian et al., c
i2004). In a compound mutant containing a mDisp12
and a null allele, this phenotype was exacerbated with l
bthe loss of additional cell types. To determine whetherisp1 was required in Shh producing or responding
ells, Cre-mediated recombination was used to reduce
isp1 activity specifically in cells expressing Shh while
eaving Disp1 intact in responding cells. These embryos
isplayed a similar phenotype to the mDisp12/ mDisp-
null embryos. Further experiments indicated that
Disp1null phenotype was partially rescued by an allele
f Shh encoding for the Shh-N lacking cholesterol mod-
fication, leading to the conclusion that mDisp1 is re-
uired in Shh-producing cells for paracrine activity of
holesterol-modified Shh.
These data do not rule out an additional requirement
or Disp1 in responding cells. Indeed, data presented
y H. Roelink (University of Washington, Seattle) lent
upport to this idea. Coimmunoprecipitations indicated
hat in mammalian cell lines expressing Ptc1, Shh in-
eracts with Disp1 in endosomes. In the absence of
tc1, however, no interaction was observed. This sug-
ested a model in which Ptc1 delivered Shh to endo-
omes, then within endosomes, Shh is transferred to
isp1. This could mediate transcytosis, facilitating the
pread of Shh from cell to cell via intracellular vesicles.
n support of this model, Roelink described experi-
ents in which the range of Shh was assayed in vitro.
S cells lacking Disp1 were differentiated into neural
ells and placed next to a Shh-producing notochord;
he resultant changes in Shh regulated gene expression
ere then assayed in the ES cells. In control cells con-
aining Disp1, the effective range of Shh was ~120 m,
hile in the absence of Disp1, the range was almost
alved to ~70 m. This suggests that Disp1 may have
role not only in Shh-producing cells but also in re-
ponding tissue and could act to promote transcytosis
f the ligand.
The importance of long-range signaling by another
ertebrate Hh protein, Indian hedgehog (Ihh), for the
ormation of limb long bones has led A.Vortkamp (MPI,
erlin) to investigate vertebrate counterparts of genes
nvolved in regulating Hh movement. Exostosin1 (Ext1),
vertebrate ortholog of the Drosophila gene ttv, be-
ongs to a family of glycosyltransferases necessary for
he synthesis of heparan sulfate chains of proteogly-
ans (HSPG). In mice carrying a hypomorphic mutation
n Ext1, there appeared to be an increase in the range
f Ihh signaling during chondrocyte differentiation (Ko-
iel et al., 2004). This contrasts with Drosophila, where
he absence of ttv completely blocks Hh movement.
ortkamp proposed that a low level of HSPG could be
ecessary to retain Hh in extracellular space, while high
evels of HSPG may negatively regulate the range of Hh
ignaling in a concentration-dependent manner. Thus,
n the absence of any Ext1 activity, Hh signaling would
e lost; however, a reduction of Ext1 activity would re-
ult in an increased range of signal. Consistent with
his, in vitro experiments indicated that addition of
eparin to cultured limbs markedly restricted the range
f Ihh.
The idea that proteins act to restrict the range of Hh
as also emerged from a number of other studies. In
rosophila, upregulation of Patched (Ptc), the Hh re-
eptor has been shown to sequester Hh protein to limit
ts range of activity (Chen and Struhl, 1996). A similar
igand-dependent transcriptional activation of verte-
rate Ptc1 is also observed, however, its significance
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gand-dependent upregulation of Ptc1 were largely nor-
mal during early development (Milenkovic et al., 1999).
The identification of Hh-interacting protein1 (Hip1), a
second, vertebrate-specific protein induced by Hh sig-
naling able to sequester ligand (Chuang and McMahon,
1999), raised the possibility that multiple proteins may
be responsible for ligand-dependent feedback in verte-
brates. Using compound mutant mice and analyzing
the development of the spinal cord, A. McMahon ele-
gantly demonstrated that this is indeed the case (Jeong
and McMahon, 2004). By generating embryos with dif-
ferent combinations of mutant Ptc1 and Hip1 alleles,
McMahon showed that incremental decreases in the
amount of ligand-dependent feedback results in an
increasing range of Shh and increasingly severe de-
fects in the patterning of the spinal cord. These data
suggest that the ligand-dependent feedback control of
Hh is conserved between flies and vertebrates, but in
vertebrates both Ptc1 and Hip1 contribute to restricting
the range of Hh.
From Outside to Inside a Cell:
Perceiving Hh Signals
In responding cells, a number of integral membrane
proteins are required to transmit Hh signals into the in-
terior of the cell (Figure 1). One key protein is the Hh
receptor Ptc (Ingham and McMahon, 2001). However,
despite its identification more than a decade ago, the
mechanism by which Ptc transduces signals still re-
mains a hotly debated and poorly understood aspect
of the Hh pathway. Ptc belongs to a growing family of
polytopic membrane-spanning proteins that contain a
region with homology to a sterol sensing domain (SSD).
This motif is conserved across phyla and present in
several membrane proteins such as Npc-1 (a protein
linked to the neurodegenerative disorder Niemann-PickFigure 1. Overview of the Hh Signal Trans-
duction Pathway in Drosophila
(A) In the absence of Hh stimulation, Ptc re-
strains Smo activity. Consequently, Ci is re-
tained in the cytoplasm through Cos2 an-
choring activity and is phosphorylated by
PKA, GSK3, and CK1, resulting in the proteo-
lytic processing of Ci to CiRep. In addition,
Su(fu) is able to exert its negative regulatory
effect on Ci. The absence of full-length Ci and
the presence of CiRep in the nucleus results
in repression of target gene expression.
(B) Upon Hh stimulation, Ptc activity is sup-
pressed and, consequently, Smo is activated
and is phosphorylated by PKA and CK1. The
interaction between Cos2 and the cytoplas-
mic tail of activated Smo inhibits Cos2 an-
choring activity and activates Fu. The forma-
tion of CiRep is suppressed and Su(Fu) no
longer anchors Ci in the cytoplasm, allowing
full-length Ci to enter the nucleus and acti-
vate transcriptional targets. Trafficking of the
proteins between different cell compart-
ments is not indicated. Blue indicates the
positive regulators and red the negative reg-
ulators of pathway. In white are components
with dual activity and/or with additional func-
tions outside the Hh pathway.type C1 disease) as well as in proteins involved in intra-
cellular cholesterol homeostasis.
To better understand the role of SSDs, M. Scott's
(Stanford University) laboratory has been investigating
the function of the Npc proteins. People or mice lacking
Npc1 have an abnormal accumulation of cholesterol in
late endosomes or lysosomes, confirming the role of
Npc proteins in cholesterol trafficking. Scott's labora-
tory showed that the Npc1 protein acts cell autono-
mously in Purkinje cells of the cerebellum to prevent
cell death. He also described a photolabile cholesterol
analog developed and applied to Npc1 protein by T.Y.
Chang (Dartmouth), which binds in vivo to Npc1 (Oh-
gami et al., 2004). Mutants were used to show that the
binding depends on conserved residues in the SSD do-
main. From this one might be tempted to conclude that
the SSD of Ptc has a role in the binding of cholesterol-
modified Hh. But this is not supported by published
data indicating that although mutations in the SSD of
Drosophila Ptc impair Ptc function, they do not interfere
with binding of cholesterol-modified Hh (Martin et al.,
2001).
The evolution of the Ptc family proteins is intriguing,
since the closest prokaryote ortholog is the resistance,
nodulation, division (RND) family of bacterial proteins.
These function as proton gradient-driven transporters,
leading to the proposal that Ptc may function in a sim-
ilar manner to translocate a modulator of the Hh path-
way across the plasma membrane (Taipale et al., 2002).
Consistent with this, expression of Npc1 in bacteria has
shown to move fatty acids and acriflavin across mem-
branes. Moreover, mutation of conserved residues of
the RND family inhibits Ptc activity. Extending the evo-
lutionary reach, P. Kuwabara (Bristol University) ex-
plored the roles of the large family of Ptc-related genes
(PTR) present in the worm C. elegans. While many of
these genes are involved in molting, two are involved
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or endocytosis. From the C. elegans screens, none of w
the recovered mutations disrupt the SSD domains or i
residues conserved in the RND family, so it remains un- p
clear which domain is functionally important in these t
proteins. t
Ptc is not the only transmembrane protein involved l
in Hh signaling, Smoothened (Smo) is also critical for d
Hh signal transduction and is believed to be responsi- t
ble for initiating intracellular signal transduction. Smo l
is a seven-pass transmembrane protein related to the a
Frizzled family of Wnt receptors with homology to G e
protein coupled receptors. Associated with Drosophila l
Smo are a number of components of the Hh signaling n
pathway including Costal-2 (Cos2), a kinesin-like pro- i
tein; Fused (Fu), a serine-threonine kinase; and the b
transcriptional mediator Cubitus interruptus (Ci) (Lum o
and Beachy, 2004; Figure 1). In unstimulated cells, path-
way activity is suppressed and a protein kinase A H
(PKA)-dependent proteolytic cleavage generates a s
transcriptional repressor form of Ci (Ci-75). Hh binding b
on Ptc reverses pathway inhibition, increases the level m
of Smo on the cell membrane, and promotes nuclear d
translocation of activated full-length Ci (Ci-155) by a
dissociation of Ci-155 from the protein complex. e
Three speakers presented evidence that PKA medi- t
ates phosphorylation of Drosophila Smo and through g
this mechanism regulates Smo activity (Jia et al., 2004; s
Apionishev et al., 2005; Zhang et al., 2004). Reminiscent n
of previous data from D. Kalderon (Columbia University, a
New York) that indicated excess PKA activity induced
Hh target genes in embryos in a Smo-dependent man- o
ner (Ohlmeyer and Kalderon, 1997), J. Jiang (South- s
western Center, Dallas) reported that in contrast to the e
inhibition of signaling by high levels of PKA activity, f
modest levels of PKA activity enhanced Hh signaling in w
the wing disc and resulted in an expansion of the region H
in which Hh signaling stabilizes Smo. By purification of a
Smo protein from Hh-treated cells, P. Beachy (Johns a
Hopkins University, Baltimore) identified 26 sites of a
phosphorylation localized in 8 clusters in the cyto- o
plasmic tail. Three of these were putative PKA phos- i
phorylation sites flanked by several potential Casein Ki- i
nase I (CK1) and a single Glycogen Synthase Kinase 3
o
(GSK3) phosphorylation sites. This arrangement is sim-
ilar to that found in Ci, where PKA phosphorylation of
ACi primes further phosphorylation events at adjacent
asites by GSK3 and CK1. Alteration of the GSK3 site had
Sno effect on Smo activity. In contrast, mutation of the
oputative PKA and CK1 phosphorylation sites in Smo to
tunphosphorylatable alanines (Smo-Pka) blocked nor-
pmal Smo activity (D. Kalderon, P. Beachy, J. Jiang).
MBeachy and Jiang reported that the mutant Smo protein
pfailed to accumulate in response to Hh signaling; in
bcontrast, Kalderon suggested that in the absence of
fPKA phosphorylation, Smo protein was stabilized inde-
dpendent of Hh signaling – clearly an issue that needs
aresolving. Conversely, substitution of multiple serine
eresidues in Smo with aspartate or glutamate, acidic
amino acids that mimic phosphoserine, resulted in a
aconstitutively active Smo molecule and phosphoryla-
btion of Fu independent of Hh ligand (J. Jiang, P. Beachy).
qThese mutant Smo proteins accumulated at the cell
surface similar to Smo protein activated by Hh signal- Hng, and a progressive enhancement of Smo activity
as observed with increasing substitution of the ser-
nes. These observations suggested that PKA and CK1
hosphorylation regulates Smo activity. Consistent with
his, inhibition of PKA or CK1 resulted in a decrease in
he level Smo protein (J. Jiang) and an inhibition of cel-
ular responses to high levels of Hh in the wing imaginal
isc and the embryo (J. Jiang, D. Kalderon). An attrac-
ive but as yet untested possibility is that different
evels of Hh signaling could be mediated by differenti-
lly phosphorylated isoforms of Smo, but, so far, no
vidence for a Hh-dependent change of the phosphory-
ation status has been documented. Moreover, there is
o evidence of Hh modulating PKA or CK1 activity rais-
ng the alternative possibility that sites on Smo may
e phosphorylated both in the presence and absence
f Hh.
Does a similar mechanism operate in the vertebrate
h signaling pathway? Surprisingly, the critical PKA
ites in Drosophila Smo are not conserved in the verte-
rate proteins, challenging the idea of a conserved
echanism. Intriguingly, vertebrate Smo is inhibited by
irect binding to the small molecule cyclopamine and
ctivated by a number of oncogenic mutations (Chen
t al., 2002). In contrast, Drosophila Smo is insensitive
o cyclopamine, and mutations that mimic the onco-
enic forms induce only very weak activity in flies. This
uggests important differences between the mecha-
ism of activation of Drosophila and vertebrate Smo,
n issue that will no doubt occupy the field in the future.
Taking advantage of the dominant-negative activity
f Smo-Pka, S. Cohen (EMBL, Heidelberg) performed a
uppresser/enhancer screen in Drosophila. One of the
nhancers identified was a kinesin-related protein dif-
erent from Cos2. Loss of this gene is cell lethal, but
eaker alleles are viable and demonstrate a reduced
h signaling phenotype. In the same screen, alleles of
new gene, jaft, affect not only signaling of Hh but
lso by Dpp and Wg. In a clone of jaft mutant cells, Wg
ccumulates in the mutant cells closest to the source
f the ligand and is unable to pass through; this is sim-
lar to cells lacking ttv, raising the possibility that jaft is
mportant for the intercellular movement of a number
f morphogens.
re There Differences between Drosophila
nd Vertebrate Hh Signaling?
tudies of vertebrate orthologs of many of the genes
riginally identified in Drosophila Hh signaling indicate
hat there are clear parallels between the signaling
athways in Drosophila and vertebrates (Ingham and
cMahon, 2001). Indeed, many of the components ap-
ear to have similar if not identical functions in verte-
rates and Drosophila. However, in addition to the dif-
erence in Smo activity noted above, a number of talks
uring the two meetings began to question whether the
ssumption of conservation is necessarily true for the
ntire pathway.
One such difference appears to be the roles of Cos2
nd Suppressor of Fused (Su(Fu)). In Drosophila, the
inding of Cos2 on the cytoplasmic tail of Smo is re-
uired for Hh signaling. M. Varjosalo (University of
elsinki) presented an analysis of the domains of mam-
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cated the region equivalent to the Cos2 binding domain
of Drosophila Smo is not required for vertebrate Smo
signaling. Moreover, analysis of two mammalian homo-
logs of Cos2, Kif27 and Kif7, indicated that neither
appeared to be involved in the Shh pathway in NIH-
3T3 cells. Of course, further study will be necessary
to decipher whether there is any redundancy between
members of the Kif family in vertebrate Hh signaling.
In contrast, expression of mammalian Su(Fu) strongly
affected the activity of the vertebrate counterparts of
Ci: Gli2 and Gli3. The Drosophila Su(Fu) mutation was
originally identified by its ability to suppress the effect
of loss of Fu. Su(Fu) interacts with Ci, and, consistent
with this, the vertebrate ortholog of Su(Fu) interacts
with Gli proteins and appears to restrain Gli-mediated
transcription by inhibiting nuclear import of Glis and/or
recruiting corepressors to Gli proteins (Dunaeva et al.,
2003). Varjosalo reported RNAi experiments with Su(Fu)
that indicated a critical role for this protein in the Shh
pathway. Further support for this idea was forthcoming
from R. Toftgard's (Karolinska Institute, Stockolm)
analysis of the phenotype of Su(Fu) knockout mice. In
contrast to Drosophila, in which loss of Su(Fu) on its
own does not have an observable affect on Hh signal-
ing, Toftgard reported that mouse embryos lacking
Su(Fu) display a dramatic phenotype. Similar to em-
bryos lacking Ptc1, the absence of Su(Fu) results in
cells responding as if constitutively exposed to high
levels of Hh signaling. Together the data raised the pos-
sibility of a difference between Drosophila and verte-
brate Hh pathway: in Drosophila, Cos2 is a central
cytoplasmic mediator of Hh signaling, whereas in verte-
brates, Su(Fu) activity appears critical.
Continuing the theme of differences between Dro-
sophila and vertebrate Hh signaling, K. Anderson
(Sloan-Kettering Institute) described a genetic screen
in mouse that has uncovered genes involved in Hh sig-
nal transduction not previously identified in Drosophila.
Four mutants, wimple, flexo/polaris, Kif3A (Huangfu et
al., 2003), and Dhc2/ling-ling have deficits in Shh sig-
naling and also defects in the formation of cellular cilia.
wimple and flexo mutations disrupt IFT172 and IFT88,
respectively, genes homologous to intraflagellar trans-
port (IFT) proteins required in the assembly of cilia and
flagella. Kif3A and ling-ling mutations affect compo-
nents of the anterograde kinesin and retrograde dynein
motor associated with IFTs. Genetic analysis indicated
that Wim, Polaris, Kif3A, and Dhc2 are required for the
generation of both transcriptional activator and repres-
sor Gli activity. Anderson also described the phenotype
of another cilia-type mutant, hennin, that exhibits an
expansion of cell types in the neural tube that require
moderate levels of Hh signaling. This increase ap-
peared to be at the expense of cells that depend on
both higher and lower levels of Hh signaling. hennin
encodes a member of ADP ribosylation factor-like
(ARL) family of small GTPase. Although the cell autono-
mous roles of the genes identified in this screen have
not been documented and biochemical experiments
will be required, it is possible that IFT proteins provide
docking sites for Gli proteins or participate in the trans-
port of Gli proteins to key cellular compartments. Alter-
natively, the formation of cilia may be a critical aspectof vertebrate Hh signaling. IFT machinery appears to
have a vertebrate-specific role in Hh signaling, since
IFT components in flies (nompB and Klp64D) that are
required for cilia formation in sensory neurons are not
necessary for Hh. Moreover, whether these genes are
important for Hh signaling in species other than the mam-
malian lineage remains to be confirmed, as to date, analy-
sis of these proteins has not been reported in chick or
zebrafish development. Nevertheless, the discovery of
a role for IFT and related genes represents a new and
unexpected twist in the Hh transduction story.
Large-scale screens for zebrafish mutants have also
revealed a number of novel components of the signal
transduction pathway. P. Ingham (Sheffield University)
described a mutant, Iguana (Igu), in which there is a
marked reduction in the generation of muscle pioneer
cells, which are normally formed in somites in response
to high levels of Hh signaling (Wolff et al., 2004). Con-
comitant with this, there is an expansion of a muscle
cell type that depends on moderate levels of Hh signal-
ing, and the generation of these cells becomes resis-
tant to inhibition by PKA. Positional cloning revealed
that Iguana encodes the zebrafish ortholog of Dzip1, a
novel zinc-finger/coiled-coil domain protein. Experiments
indicated that Dzip1 was normally present in the cyto-
plasm, but on blockade of PKA activity, Dzip1 moved
to the nucleus, suggesting that it may function in the
nuclear-cytoplasmic shuttling of Gli proteins. Intrigu-
ingly, mutant Dzip1 from Iguana embryos was constitu-
tively nuclear. From these data, Ingham concluded that
Igu is required for full transcriptional activation by Gli
proteins.
Spatial Gradient and Temporal Integration
of Hh Signaling in Vertebrates
In vertebrates, the ability of graded Shh signaling to
organize cellular pattern serves as a paradigm for dis-
secting the molecular mechanisms of developmental
morphogen activity. In ventral regions of the spinal
cord, Shh acts directly in a concentration-dependent
manner to control the emergence, in precise spatial or-
der, of distinct neuronal subtypes (Jessell, 2000). A.
Joyner (Skirball Institute) and C.C. Hui's (Hospital for
Sick Children, Toronto) analysis of mice lacking indivi-
dual or combinations of Gli transcription factors indi-
cates that these proteins play a central role in graded
Shh signaling. Three different Gli proteins, Gli1, 2, and
3, are present in vertebrates and implicated in mediat-
ing Shh responses. Gli2 and 3 contain transcriptional
repression and activation domains, whereas Gli1 con-
tains only an activation domain. Gli1 expression de-
pends on Shh signaling, and the absence of Gli1 ap-
pears to be compensated for by Gli2, which provides
the major activator input for the pathway. In addition,
the lack of Gli2 function can be rescued by Gli1, sug-
gesting that the repression domain of Gli2 is not neces-
sary for Shh-dependent patterning (Bai and Joyner,
2001). Adding to the complexity, both speakers showed
that Gli3, although normally contributing repressor
function to the patterning processes regulated by Shh,
can have a positive role in Shh signaling albeit more
limited than Gli2. Finally, analysis of the neural tube of
embryos lacking all Gli gene expression indicated that
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produced, the spatial pattern of generation is severely p
disrupted, indicating that patterning of the ventral spi- a
nal cord depends on Gli proteins (Bai et al., 2004; Mo- s
toyama et al., 2003). Building on this work, J. Briscoe w
(NIMR, London) argued that in the neural tube, Gli pro- e
teins operate by establishing a gradient of Gli transcrip- t
tional activity in response to graded Shh signaling (Sta- a
mataki et al., 2005). Three Gli constructs displaying S
different levels of transcriptional activity were sufficient t
to recapitulate the cellular responses characteristic of b
graded Shh. Quantitative measurements indicated that t
the incremental 2- to 3-fold changes in Shh concentra- i
tion which determine alternative neuronal subtypes in p
vitro could be mimicked by similar small changes in the
level of Gli activity in vivo, suggesting that the strength C
of Shh signaling is transduced, without substantial am- P
plification, into a gradient of Gli activity, which is suffi- f
cient to orchestrate ventral neural tube patterning. i
Although cells in the ventral neural tube respond to n
a gradient of Shh signaling, this may not be as straight- [
forward as initially thought. By focusing on the three a
most ventral cell types in the neural tube, J. Ericson c
(Karolinska Institute, Sweden) provided evidence that n
how neural cells respond to and interpret Shh signaling (
is modulated over time. First, the temporal expression h
of homeodomain transcription factors alters the intrin- m
sic responsiveness of cells to Shh, perhaps by regulat- I
ing the expression of Gli proteins, and this change in S
responsiveness determines the spatial distribution of t
the two most ventral neuronal subtypes. Second, the s
switch between the induction of the ventral midline l
cells — nonneuronal floor plate — and the adjacent in- p
terneuron population is determined by a shift in the po- t
tential of progenitors from nonneuronal-to-neuronal. f
These studies suggest that precise temporal alterations
s
in the competence of neural progenitors to respond to
e
Shh are integral components of the morphogen activity
a
of Shh and account for some of the complexities in
wventral neural tube patterning.
iIn the limb bud, Shh also acts as a morphogen. Shh
mprotein, produced by the posteriorly located zone of
cpolarizing activity (ZPA), establishes digit identity and
rpattern along the anterior-posterior axis. Whether, in
Mthis tissue, Shh operates directly as a concentration-
bdependent, long-range morphogen has long be contro-
dversial. C. Tabin (Harvard Medical School, Boston) and
aA. Joyner (NYU Medical School, New York) presented
elegant and complementary studies that suggested a
tmodel that could reconcile previous observations. In all
ctissues analyzed so far, Shh signaling induces Gli1 ex-
ppression. Joyner took advantage of this observation to
sgenerate mice in which an inducible form of Cre is in-
(serted in the Gli1 locus, thus providing a method to
sgenetically mark Shh-responding cells (Ahn and Joyner,
l2004). Using this allele, cumulative Shh signaling was
iassessed at different time points, and this analysis sug-
tgested that all limb mesenchyme cells except those in
othe most anterior digit respond to Shh. Moreover, the
tcells responding to Shh signaling, as reported by Gli1
iexpression, appeared to change over time along the
iA-P axis. Tabin used a similar recombinase-based
tmapping strategy to examine the fate of Shh-express-
ing cells (Harfe et al., 2004). This analysis indicated that bhe descendants of the Shh-producing cells encom-
assed all cells in the two most posterior digits and
lso contributed to the middle digit. Together the data
uggested that specification of digit identity correlates
ith differential Shh responses, which may in part be
stablished by the duration of exposure to Shh, in addi-
ion to the strength of Shh signaling. These data could
ccount for the previous studies which suggested that
hh acts in a graded manner in the limb but questioned
he requirement for long-range Shh signaling. Thus, in
oth the spinal cord and the limb, in addition to a spa-
ial gradient of signaling, temporal integration of signal-
ng or the interpretation of signaling appears to be im-
ortant for patterning.
ancer, Stem Cells—Hh Enters the Clinic
erhaps one of the most striking themes to emerge
rom the meetings was the importance of Hh signaling
n a range of clinically significant areas. Loss of Hh sig-
aling in embryos results in holoprosencephaly (HPE
Roessler et al., 1996]). HPE is the most common anom-
ly of the developing forebrain in humans: 1:250 human
onceptions develop with HPE, 98% of which sponta-
eously terminate before birth. M. Muenke's laboratory
NIH, Bethesda) has identifed genetic mutations that
ave been found in those born with HPE. They include
utations in Shh, Disp1, and a number of other genes.
nterestingly, mutations have not been recovered in
mo, Hip, or Gli1; this may be because mutations in
hese genes do not cause HPE. Alternatively, it is pos-
ible that mutations in these genes result in embryonic
ethality and spontaneous abortion. The severity and
resentation of HPE varies considerably: to some ex-
ent this is due to the nature of the causative mutation,
or example, the same facial characteristics are ob-
erved in individuals with loss-of-function mutations in
ither Gli2 or Shh, but loss of Gli2 results in pituitary
bnormalities instead of the brain defects associated
ith Shh mutations. However, even between individuals
n the same family, harboring the same HPE-causing
utation, the severity of HPE can range from sub-clin-
ial to lethal. This suggests that other genetic or envi-
onmental factors must modify the penetrance of disease.
eunke raised the possibility that one such factor could
e the availability of cholesterol during critical periods of
evelopment, however studies to address this question
re still ongoing.
It has become apparent over the last few years that
he inappropriate activation of Hh signaling is also clini-
ally significant, with as many as 25% of tumors dis-
laying unregulated Hh signaling. Perhaps best under-
tood is the association between basal cell carcinoma
BCCs) and Hh signaling. Providing a historical per-
pective, R. Gorlin (University of Minnesota, Minneapo-
is) described the original cases that prompted him to
dentify Nevoid basal cell carcinoma syndrome and led
o the identification of mutations in Ptc1 as the cause
f the multiple developmental defects and suscep-
ibility to BCC characteristic of this syndrome. Examin-
ng normal skin development, C.C. Hui presented data
ndicating that Shh plays a critical mitogenic role in ini-
iating the development of hair follicles and does this
y promoting the activator function of Gli2 as well as
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Furthermore, Gli activity regulates transition through
the G1 restriction point by controlling the expression of
cell cycle components cyclin D1, D2, and N-myc at
both transcriptional and posttranscriptional levels.
Taking advantage of the involvement of Shh signaling
in BCCs, A. Oro (Stanford University) developed a
microarray screen to identify target genes upregulated
in these tumors. One of the genes identified corres-
ponds to the actin remodeling factor BEG4/MIM, a
member of the Wasp family implicated in cytoskeleton
reorganization during T cell migration (Callahan et al.,
2004). Oro presented evidence that although Gli1 alone
could not recapitulate Shh-mediated epidermal prolif-
eration and invasion of human epidermal grafts in nude
mice, coexpression of Gli1 and BEG4/Mim was able to
trigger this effect. BEG4/MIM coprecipitated with Gli1
and Su(Fu) through domains different from those used
for actin binding, suggesting that it represents a new
regulator of Gli activity during growth and tumori-
genesis.
Unregulated Hh signaling is involved in the genesis
of other types of cancers including pancreatic tumors,
rhabdomyosarcomas, and small cell lung cancers
(Beachy et al., 2004; Ruiz i Altaba et al., 2002). P. Beachy
and A. Ruiz i Altaba (University of Geneva) extended
the tumorigenesis studies to prostate cancer. Beachy
presented evidence that Hh pathway activity, in clinical
isolates, correlated with the more aggressively meta-
static tumors, and that forced expression of Gli1 in cells
from nonmetastatic tumors could convert them into in-
vasive metastases (Karhadkar et al., 2004). The tumori-
genic state requires the unregulated continuous pro-
duction of endogenous Hh ligands and is dependent
on the expression of Smoothened. As with other types
of tumors, in vivo experiments with the Smo inhibitor
cyclopamine indicated that the lethality of tumors could
be abrogated by inhibition at this level of the pathway.
Moreover, cessation of treatment did not result in re-
growth of the tumors. Ruiz i Altaba independently re-
ported similar findings (Sanchez et al., 2004) also dem-
onstrating that the proliferation of primary prostate
tumor cultures could be blocked with cyclopamine or
Shh-neutralizing antibodies; conversely, addition of
Shh could potentiate tumor cell proliferation. In addi-
tion, Gli1 RNA interference inhibited the proliferation of
prostate tumor cells, illustrating an essential role for Gli-
mediated transcription in this process. These studies
raise the question of how activation of Hh signaling pro-
motes tumorigenesis. One attractive hypothesis pro-
posed by both speakers is that the activity of Hh signal-
ing is required for the normal growth and regeneration
of prostate epithelium from stem cells, and inappropri-
ate activation of repair and regeneration pathways by
continuous Hh signaling promotes tumorigenesis.
Whether Hh signaling is required solely in an autocrine
fashion to promote cell proliferation and allow cells to
achieve a metastatic state or whether the production of
Hh ligands have additional nonautonomous roles, for
example, by signaling to stromal cells, remains to be
determined.
The idea that Hh signaling may be involved in the
mobilization and proliferation of tissue stem cells was
further supported by studies in the CNS reported byA. Ruiz i Altaba and A. Joyner. Ruiz i Altaba provided
evidence that single periventricular cells with astrocytic
features expressed Gli1. Genetic inhibition of Shh sig-
naling results in the loss of neural stem cell forming
potential from embryonic cortex, and the pharmacolog-
ical inhibition of Shh signaling in adult mice resulted in
a reduction in the proliferation of cells in the SVZ
(Palma and Ruiz i Altaba, 2004; Palma et al., 2005). In
support of this, Joyner reported evidence in adult mice
that Gli1 expression, assayed using transgenic mice, is
upregulated in quiescent neural stem cells by endoge-
nous Shh signaling, and these cells are ultimately incor-
porated as neurons into the olfactory bulb. Together the
data provide evidence that Shh signaling regulates the
proliferation and homeostasis of at least some tissue-
specific stem cells.
The clinical importance of Hh signaling has stim-
ulated the search for small molecule modulators of the
signaling pathway that could be therapeutically useful.
L. Rubin (Curis Inc., Cambridge) provided an update of
Curis’ efforts. Rubin described assays of a potent Hh
signaling antagonist that, in partnership with Genen-
tech, will be tested in clinical trails for efficacy against
BCC. If successful, this could provide the stimulus to
develop drug treatments for other Hh-dependent can-
cers. Agonists may also find clinical uses. Rubin de-
scribed a molecule that binds to Smo and is able to
simulate the effect of Hh signaling in standard assays
for Hh activity. Significantly, in a mouse model, admin-
istration of this molecule aided functional recovery
following the induction of a stroke. Remarkably, in an-
other mouse model used to study depression, the same
agonist also improved performance to an extent similar
to an existing antidepressant. Rubin suggested that
these effects could depend on the neural protective ef-
fect of Hh signaling (Machold et al., 2003) and/or the
stem cell-stimulating properties of Hh signaling intro-
duced by other speakers at the meetings. Clearly more
work is required to understand how agonists could be
used therapeutically and how Hh signaling is operating
in these circumstances; however, these data open up
exciting possibilities which will no doubt receive con-
siderable attention in the future.
Conclusion
Together, the two meetings covered a broad range of
topics, from fundamental aspects of molecular and cel-
lular biology to applied studies with clinical and social
importance. What started less than a quarter century
ago as a mutant fruit fly is today a textbook example of
how understanding basic developmental mechanisms
leads to medical advances. Clearly, the clinical rele-
vance of Hh signaling has stimulated the field, and to
see the progress that has been made in this area was
impressive. But equally striking was the realization of
how much is still unknown about many aspects of Hh
signaling, from the many gaps in our knowledge of sig-
nal transduction mechanisms to understanding the
physiological roles of Hh signaling. Moreover, one of
the features that has come to define the Hh signaling
field is the regularity of surprises, whether it’s the dis-
covery of the unique lipidation event during Hh synthe-
sis which makes Hh the only identified cholesterol
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150Smodified protein or the finding that so many cancers
8display unregulated Hh signaling. Indeed, as F. Charron
G(Standford University) reminded us, perhaps the most
vrecent surprise is that, in addition to controlling gene
6
expression, Hh appears to act as an axon guidance
H
molecule (Charron et al., 2003). What surprises will T
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